Skip to main content

Advertisement

SpringerLink
Log in

Deoxycytidine kinase is downregulated in Ara-C-resistant acute myeloid leukemia murine cell lines

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Yin B, Kogan SC, Dickins RA, Lowe SW, Largaespada DA . Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia. Exp Hematol 2006; 34: 631–641.

    Article  CAS  PubMed  Google Scholar 

  2. Shi JY, Shi ZZ, Zhang SJ, Zhu YM, Gu BW, Li G et al. Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients. Pharmacogenetics 2004; 14: 759–768.

    Article  CAS  PubMed  Google Scholar 

  3. Veuger MJ, Honders MW, Landegent JE, Willemze R, Barge RM . High incidence of alternatively spliced forms of deoxycytidine kinase in patients with resistant acute myeloid leukemia. Blood 2000; 96: 1517–1524.

    CAS  PubMed  Google Scholar 

  4. Song JH, Kim SH, Kweon SH, Lee TH, Kim HJ, Kim HJ et al. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells. Int J Oncol 2009; 34: 1165–1171.

    CAS  PubMed  Google Scholar 

  5. Jiang Y, Prunier C, Howe PH . The inhibitory effects of disabled-2 (Dab2) on Wnt signaling are mediated through Axin. Oncogene 2008; 27: 1865–1875.

    Article  CAS  PubMed  Google Scholar 

  6. Akyerli CB, Beksac M, Holko M, Frevel M, Dalva K, Ozbek U et al. Expression of IFITM1 in chronic myeloid leukemia patients. Leuk Res 2005; 29: 283–286.

    Article  CAS  PubMed  Google Scholar 

  7. Kongkham PN, Northcott PA, Ra YS, Nakahara Y, Mainprize TG, Croul SE et al. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma. Cancer Res 2008; 68: 9945–9953.

    Article  CAS  PubMed  Google Scholar 

  8. Chuthapisith S, Bean BE, Cowley G, Eremin JM, Samphao S, Layfield R et al. Annexins in human breast cancer: possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer 2009; 45: 1274–1281.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge support from the Leukemia and Lymphoma Society of America (LLS 7019-04, Specialized Center of Research) and the Leukemia Research Fund (University of Minnesota). We especially thank Teng Zhang for his assistance with the drug assay and Natashay J Bailey for her work on the growth assay.

Author information

Authors and Affiliations

  1. Department of Genetics, Cell Biology, and Development, The Masonic Cancer Center at the University of Minnesota, Minneapolis, MN, USA

    S K Rathe & D A Largaespada

Authors
  1. S K Rathe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D A Largaespada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S K Rathe.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rathe, S., Largaespada, D. Deoxycytidine kinase is downregulated in Ara-C-resistant acute myeloid leukemia murine cell lines. Leukemia 24, 1513–1515 (2010). https://doi.org/10.1038/leu.2010.88

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.88

  • Springer Nature Limited

This article is cited by

Search

Navigation